Psychopharmacological Enhancement

被引：37
作者：
Glannon, Walter [1 ,2 ]
机构：
[1] Univ Calgary, Dept Philosophy, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada
来源：
NEUROETHICS | 2008年 / 1卷 / 01期
基金：
加拿大健康研究院;
关键词：
Authenticity; Anxiety; Attention; Memory; Methylphenidate; Modafinil; Propranolol;
D O I：
10.1007/s12152-008-9005-9
中图分类号：
B82 [伦理学（道德学）];
学科分类号：
摘要：
Many drugs have therapeutic off-label uses for which they were not originally designed. Some drugs designed to treat neuropsychiatric and other disorders may enhance certain normal cognitive and affective functions. Because the long-term effects of cognitive and affective enhancement are not known and may be harmful, a precautionary principle limiting its use seems warranted. As an expression of autonomy, though, competent individuals should be permitted to take cognition- and mood-enhancing agents. But they need to be aware of the risks in chronic use of these agents and to take responsibility for their effects. A reasonable middle ground between these positions is to warn those who choose to enhance that doing so entails risks.
引用
收藏
页码：45 / 54
页数：10
相关论文
共 33 条
[1]   Memory suppressor genes: Inhibitory constraints on the storage of long-term memory [J].
Abel, T ;
Martin, KC ;
Bartsch, D ;
Kandel, ER .
SCIENCE, 1998, 279 (5349) :338-341
[2]  
[Anonymous], 1989, IMPORTANCE WHAT WE C
[3]  
Borges J.L., 1944, Ficciones
[4]   The serotonin syndrome [J].
Boyer, EW ;
Shannon, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1112-1120
[5]  
CAPLAN A, 2004, CEREBRUM, V6, P13
[6]   The promise and predicament of cosmetic neurology [J].
Chatterjee, A .
JOURNAL OF MEDICAL ETHICS, 2006, 32 (02) :110-113
[7]  
Damasio A.R., 1994, DESCARTES ERROR EMOT
[8]   Neuroscience and ethics: Intersections [J].
Damasio, Antonio .
AMERICAN JOURNAL OF BIOETHICS, 2007, 7 (01) :3-7
[9]  
DeGrazia David., 2005, Human Identity and Bioethics
[10]  
Dodd M. Leann, 2005, ARCH NEUROL-CHICAGO, V62, P579
1234